An antibody for RSV: Synagis (palivizumab) is a medication that is made of antibodies to a virus called rsv. Making a pure solution of such a molecule is very complex and costly. A shot of synagis (palivizumab) gives the recipient instant but partial protection from the worst severity of RSV infection, for young infants and so is used in prematures and infants with lung diseases.
Answered 5/28/2016
5.7k views
4 doctors weighed in across 2 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question